Pharmaceutical waste system

US11229932B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-11229932-B2
Application numberUS-201716324273-A
CountryUS
Kind codeB2
Filing dateSep 8, 2017
Priority dateSep 9, 2016
Publication dateJan 25, 2022
Grant dateJan 25, 2022

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

A pharmaceutical waste system for treating a residual pharmaceutical composition disposed in a pharmaceutical dispenser includes an extraction stage, a pharmaceutical dispenser coupler, and a pharmaceutical waste treatment stage. The extraction stage is in fluid communication with the pharmaceutical dispenser and is configured to extract at least a portion of the residual pharmaceutical composition from the pharmaceutical dispenser. The pharmaceutical dispenser coupler is configured to couple the pharmaceutical dispenser to the extraction stage. The pharmaceutical waste treatment stage is in fluid communication with the extraction stage and is configured to change the residual pharmaceutical waste composition extracted from the pharmaceutical dispenser in one of a chemical and physical manner. The present disclosure also provides a method of disposing of a residual pharmaceutical composition from a pharmaceutical dispenser.

First claim

Opening claim text (preview).

What is claimed is: 1. A pharmaceutical waste system for treating a residual pharmaceutical composition disposed in an IV bag, the pharmaceutical waste system comprising: an extraction stage for being placed in fluid communication with the IV bag, with said extraction stage being configured to extract at least a portion of the residual pharmaceutical composition from the IV bag; a pharmaceutical dispenser coupler configured to couple the IV bag to said extraction stage; a pharmaceutical waste treatment stage in fluid communication with said extraction stage, said pharmaceutical waste treatment stage being configured to change the residual pharmaceutical composition extracted from the IV bag in one of a chemical and physical manner; and a main housing, with said extraction stage and said pharmaceutical waste treatment stage at least partially disposed within said main housing. 2. The pharmaceutical waste system of claim 1 wherein said pharmaceutical waste treatment stage is further defined as a separation stage, said separation stage being configured to separate the residual pharmaceutical composition extracted from the IV bag into a purified waste portion and a contaminated waste portion. 3. The pharmaceutical waste system of claim 2 wherein said separation stage comprises a filter assembly comprising a filter housing and a filter media disposed within said filter housing. 4. The pharmaceutical waste system of claim 3 wherein said filter media is configured to bind with at least a portion of the residual pharmaceutical composition extracted from the IV bag such that said filter media retains said contaminated waste portion. 5. The pharmaceutical waste system of claim 3 wherein said filter media comprises activated charcoal. 6. The pharmaceutical waste system of claim 3 wherein said filter assembly comprises a replaceable cartridge removably coupled to said filter housing, with said filter media disposed within said replaceable cartridge. 7. The pharmaceutical waste system as set forth in claim 1 wherein said pharmaceutical waste treatment stage is further defined as a chemical treatment stage, with said chemical treatment stage being configured to treat the residual pharmaceutical composition extracted from the IV bag in a chemical manner. 8. The pharmaceutical waste system of claim 7 wherein said chemical treatment stage comprises a chemical treatment vessel in fluid communication with said extraction stage, and a chemical agent disposed within said chemical treatment vessel. 9. The pharmaceutical waste system of claim 8 wherein said chemical agent comprises a deactivator, a denaturant, an oxidizer, and combinations thereof. 10. The pharmaceutical waste system as set forth in claim 1 wherein said extraction stage comprises a pump in fluid communication with said pharmaceutical dispenser coupler. 11. The pharmaceutical waste system of claim 10 wherein the pharmaceutical dispenser coupler is further defined as a first pharmaceutical dispenser coupler configured to couple to a first IV bag, and with the pharmaceutical waste system further comprising a second pharmaceutical dispenser coupler configured to couple to a second IV bag, wherein said extraction stage comprises a manifold, said manifold comprising, one or more manifold inlets configured to receive the residual pharmaceutical composition from the first and second IV bags, and a manifold outlet configured to output the residual pharmaceutical composition received from the first and second IV bags to said pump. 12. The pharmaceutical waste system of claim 1 wherein said main housing further comprises a security mechanism configured to prevent unauthorized access to said extraction stage and said pharmaceutical waste treatment stage. 13. The pharmaceutical waste system as set forth in claim 1 wherein said extraction stage comprises a reservoir in fluid communication with said pharmaceutical waste treatment stage, with said reservoir upstream of said pharmaceutical waste treatment stage for temporarily storing the residual pharmaceutical composition extracted from the IV bag. 14. The pharmaceutical waste system of claim 1 further comprising a waste analysis stage in fluid communication with one of the extraction stage and the pharmaceutical waste treatment stage, with the waste analysis stage being configured to analyze an output or an input of one of the extraction stage and the pharmaceutical waste treatment stage.

Assignees

Inventors

Classifications

  • Chemical treatment, e.g. pH adjustment or oxidation (involving an extraction step B09B3/80) · CPC title

  • Medical waste · CPC title

  • B09B3/80Primary

    involving an extraction step · CPC title

  • from the pharmaceutical industry, e.g. containing antibiotics · CPC title

  • Destroying solid waste or transforming solid waste into something useful or harmless · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US11229932B2 cover?
A pharmaceutical waste system for treating a residual pharmaceutical composition disposed in a pharmaceutical dispenser includes an extraction stage, a pharmaceutical dispenser coupler, and a pharmaceutical waste treatment stage. The extraction stage is in fluid communication with the pharmaceutical dispenser and is configured to extract at least a portion of the residual pharmaceutical composi…
Who is the assignee on this patent?
Stryker Corp
What technology area does this patent fall under?
Primary CPC classification B09B3/80. Mapped technology areas include Operations & Transport.
When was this patent published?
Publication date Tue Jan 25 2022 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).